✦ LIBER ✦

Besifloxacin Ophthalmic Suspension 0.6% Administered Twice Daily for 3 Days in the Treatment of Bacterial Conjunctivitis in Adults and Children

✍ Scribed by Jesse DeLeon, Bruce E. Silverstein, Catherine Allaire, Lynne S. Gearinger, Kirk M. Bateman, Timothy W. Morris, Dr Timothy L. Comstock

Book ID: 119931462
Publisher: Springer International Publishing AG
Year: 2012
Tongue: English
Weight: 200 KB
Volume: 32
Category: Article
ISSN: 1179-1918
DOI: 10.2165/11632470-000000000-00000

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Tolerability of Besifloxaci

Efficacy and Tolerability of Besifloxacin Ophthalmic Suspension 0.6% Administered Twice Daily for 3 Days in the Treatment of Bacterial Conjunctivitis: A Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel-Group Study in Adults and Children

✍ Bruce E. Silverstein; Catherine Allaire; Kirk M. Bateman; Lynne S. Gearinger; Ti 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 499 KB

Safety and Tolerability of Besifloxacin

Safety and Tolerability of Besifloxacin Ophthalmic Suspension 0.6% in the Treatment of Bacterial Conjunctivitis

✍ Dr Timothy L. Comstock, Michael R. Paterno, Heleen H. DeCory, Dale W. Usner 📂 Article 📅 2010 🏛 Springer International Publishing AG 🌐 English ⚖ 154 KB

Phase III efficacy and safety study of b

Phase III efficacy and safety study of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis

✍ Tepedino, Michael E.; Heller, Warren H.; Usner, Dale W.; Brunner, Lynne S.; Morr 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 304 KB